Previous study showed siRNA directed against CXCR4 could inhibit breast cancer migration in vitro (Liang et al, 2005), but the influence of CXCR4 knockdown on pancreatic cancer was hardly known. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.